Abstract
In this issue of the Journal of Clinical Sleep Medicine, Rosenthal et al.1 describe the results of a study assessing the ability of nasal expiratory resistors (PROVENT™) to reduce sleep disordered breathing in a group of OSA patients with a relatively wide range of apnea severity. A study such as this raises a number of fundamental questions:
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have